Testing Laboratories - Insider Trading Data
Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Testing industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.
Testing Laboratories - Insider Buy/Sell Ratio
Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.
We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).
Testing Laboratories - Transaction History
Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.
| Tran Date |
Security | Form | Insider | Code | Direct | Share Price |
Shares Changed |
|
|---|---|---|---|---|---|---|---|---|
| 2021-03-02 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | 53.17 | 29,895 | ||
| 2021-03-02 | NEO / NeoGenomics, Inc. | 4 | SHOVLIN ROBERT J. | D | 53.17 | 38,688 | ||
| 2021-03-02 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | 5,276 | |||
| 2021-03-02 | NEO / NeoGenomics, Inc. | 4 | SHOVLIN ROBERT J. | D | 6,827 | |||
| 2021-03-02 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | 56,423 | |||
| 2021-03-01 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | -2,339 | |||
| 2021-03-01 | NEO / NeoGenomics, Inc. | 4 | Pedulla Denise E | D | -212 | |||
| 2021-03-01 | NEO / NeoGenomics, Inc. | 4 | SHOVLIN ROBERT J. | D | -742 | |||
| 2021-03-01 | NEO / NeoGenomics, Inc. | 4 | Bonello William | D | -500 | |||
| 2021-03-01 | NEO / NeoGenomics, Inc. | 4 | BALLIET JENNIFER | D | -212 | |||
| 2021-03-01 | NEO / NeoGenomics, Inc. | 4 | McKenzie Kathryn B | D | -169 | |||
| 2021-01-07 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C | D | 22.52 | 4,269 | ||
| 2021-01-07 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C | D | -4,269 | |||
| 2021-01-07 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C | D | -3,017 | |||
| 2021-01-07 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C | D | -10,000 | |||
| 2021-01-07 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | -100,000 | |||
| 2021-01-07 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C | D | 11.60 | 3,017 | ||
| 2021-01-07 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C | D | 7.27 | 10,000 | ||
| 2021-01-07 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 7.15 | 100,000 | ||
| 2021-01-05 | APDN / Applied DNA Sciences, Inc. | 4 | Hayward James A | D | 80,000 | |||
| 2020-12-30 | DIGP / Hypha Labs, Inc. | 4 | RABEN BRUCE I | D | 0.0225 | 900,000 | ||
| 2020-12-25 | DIGP / Hypha Labs, Inc. | 4 | Peterson Todd A | D | 728,155 | |||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | 9.22 | 13,333 | ||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | 13.87 | 16,666 | ||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | -16,666 | |||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | -13,333 | |||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | -20,000 | |||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | -50,000 | |||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | 6.98 | 50,000 | ||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | 19.60 | 9,005 | ||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | 7.27 | 20,000 | ||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | -9,005 | |||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 51.67 | -25,000 | ||
| 2020-12-14 | NEO / NeoGenomics, Inc. | 4 | Weiss Lawrence Martin | D | 51.06 | -20,200 | ||
| 2020-12-11 | NEO / NeoGenomics, Inc. | 4 | BALLIET JENNIFER | D | 8.03 | 15,000 | ||
| 2020-12-11 | NEO / NeoGenomics, Inc. | 4 | BALLIET JENNIFER | D | -15,000 | |||
| 2020-12-11 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 50.52 | -25,000 | ||
| 2020-12-11 | NEO / NeoGenomics, Inc. | 4 | BALLIET JENNIFER | D | 49.99 | -15,000 | ||
| 2020-12-10 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 50.30 | -20,000 | ||
| 2020-12-07 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 49.45 | -45,658 | ||
| 2020-12-04 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 48.07 | -64,394 | ||
| 2020-12-04 | NEO / NeoGenomics, Inc. | 4 | Johnson Kevin C | D | 47.88 | -24,683 | ||
| 2020-12-03 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 48.03 | -19,948 | ||
| 2020-12-02 | NEO / NeoGenomics, Inc. | 4 | Bonello William | D | 8.03 | 8,000 | ||
| 2020-12-02 | NEO / NeoGenomics, Inc. | 4 | Bonello William | D | -8,000 | |||
| 2020-12-02 | NEO / NeoGenomics, Inc. | 4 | Bonello William | D | 46.80 | -8,000 | ||
| 2020-11-25 | NEO / NeoGenomics, Inc. | 4 | CARDOZA GEORGE | D | 7.52 | 77,074 | ||
| 2020-11-25 | NEO / NeoGenomics, Inc. | 4 | CARDOZA GEORGE | D | -77,074 | |||
| 2020-11-25 | NEO / NeoGenomics, Inc. | 4 | CARDOZA GEORGE | D | 45.48 | -77,074 | ||
| 2020-11-24 | NEO / NeoGenomics, Inc. | 4 | CARDOZA GEORGE | D | 7.52 | 72,926 |
